Conflixis Releases 2024 Open Payments Report Shedding Light on Risk in Financial Relationships Across Healthcare
2024年7月23日 - 11:00PM
ビジネスワイヤ(英語)
Report finds industry-wide risk signal amidst
noise of 85 million transactions, showcasing power of Conflixis’
AI-enabled platform.
Conflixis, a new conflicts of interest risk management
technology provider, today released its inaugural 2024 Open
Payments Report, revealing critical insights into the financial
relationships between healthcare providers and the pharmaceutical
and medical device industries.
The report uncovers patterns of potentially inappropriate
remuneration and shows that although the Open Payments program has
enhanced transparency, disclosure alone has not deterred healthcare
companies from patterns of potentially inappropriate payments, many
of which have in fact grown more common.
“Our goal with the Open Payments Report is not to spotlight
headline-grabbing anecdotes, but rather to tell the larger story of
how money moves between industry and providers,” said Conflixis CEO
Aaron Narva. “It’s a call to action for stakeholders across the
industry.”
See recent coverage of Conflixis in the Wall Street Journal.
High Level Findings:
Many payments appear to camouflage inappropriate remuneration,
including irregular combinations of consulting engagements,
speaking fees, promotional fees and in-kind payments for food and
beverage.
- Industry guidelines about interactions with providers suggest
that food and beverage payments be “modest” and not part of an
entertainment or recreational event, yet high dollar food and
beverage payments and group events reached their highest levels
ever in 2023.
- Despite warnings from regulators that repeat payments for
speaking engagements or for attendance of non-educational events
constitute a red flag, there were over 6,600 instances in which a
company made at least ten payments to a provider to participate in
a non-educational or non-consulting event in 2023.
- Contrary to voluntary guidance (and some Anti-Kickback
charges/civil settlements) from the federal government that
honoraria payments are “generally reserved for a brief, one-time
activity,” repeat honoraria payments to the same provider reached
more than $33 million in 2023.
- Drug and device makers who fund researchers evaluating their
medical technologies have also made $2.3 billion in parallel cash
and in-kind payments to them since 2016, threatening the integrity
of the scientific enterprise.
Underscoring the value of technology in effective risk
management, Narva said: “The insights our technology has uncovered
emphasize the importance of transparency and the critical role that
data analysis plays in helping healthcare employers avoid the steep
costs of conflicts.”
For a copy of the report visit
https://www.conflixis.com/theopreport.
CMS Open Payments Database
The Centers for Medicare and Medicaid Services (CMS) established
the Open Payments program in 2013 to enhance transparency in
financial relationships between healthcare providers and the
pharmaceutical and medical device industries. The database contains
detailed information on payments made to providers, including fees
for consulting, speaking, and honoraria, as well as in-kind
payments for food and beverage, travel, and lodging.
About Conflixis
Conflixis is a conflict of interest risk management company that
is changing the way organizations identify, manage and mitigate
risk arising from conflicts of interest. Leveraging decades of
experience in anti-corruption, anti-money laundering and fraud,
Conflixis provides a sophisticated platform for identifying and
managing the everyday impact of conflicts of interest. Our unique
platform offers real-time, customized analysis of both internal
data sets and the public record, enabling clients to go beyond the
file and forget systems of the past.
For more information on the 2024 Open Payments Report or to
learn about Conflixis’ technology, please contact:
Jessica Francis
info@conflixis.com
www.conflixis.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240719587265/en/
Conflixis Jessica Francis info@conflixis.com